氯吡格雷联合前列地尔治疗急性脑梗死的临床疗效观察
2016-02-06贾永林尹世琦张保华付志新
贾永林尹世琦张保华付志新
氯吡格雷联合前列地尔治疗急性脑梗死的临床疗效观察
贾永林1尹世琦2张保华1付志新1
目的 对急性脑梗死采用氯吡格雷联合前列地尔治疗的临床效果进行分析。方法 选取医院收治的134例急性脑梗死患者,常规阿司匹林治疗的67例纳入对照组,利用氯吡格雷联合前列地尔治疗的67例划入观察组,利用卒中量表NIHSS对治疗后患者神经功能进行评定,并比较其他生化指标。结果 两组患者卒中量表评分结果,观察组平均(1.96±0.78)分低于对照组(4.79±1.65)分;比较两组患者治疗后生化指标,CRP、TNF-α、IL-6,观察组低于对照组,差异有统计学意义(P<0.05)。结论 氯吡格雷可与前列地尔共同用于急性脑梗死治疗中,对患者神经功能恢复以及其他生化指标的改善都可起到重要作用,可在临床实践中进行推广。
氯吡格雷;前列地尔;急性脑梗死;临床疗效
【Abstract】
Objective To analyze the clinical effect of acute cerebral infarction treated with clopidogrel combined with alprostadil. Methods 134 cases of acute cerebral infarction patients, conventional aspirin treatment of 67 cases were included in the control group, the therapeutic used of clopidogrel combined with alprostadil in 67 patients assigned to the observation group,neurological function of two groups were evaluated by stroke scale NIHSS, other biochemical indexes were analyzed and compared. Results Two groups of patients with Stroke Scale score results: The observed group (1.96±0.78) was lower than control group(4.79±1.65), compared two groups of patients after biochemical indexes of CRP, TNF-α, IL-6, the observation group was lower than that in the control group, showed significant difference(P<0.05). Conclusion Clopidogrel and alprostadil jointly for the treatment of acute cerebral infarction, in the recovery of neurological function and other biochemical parameters improve can play an important role, it is popularized in clinical practice.
【Key words】Clopidogrel, Alprostadil, Acute cerebral infarction, Clinical curative effect
急性脑梗死多因脑内血液循环出现异常,发生急性缺血性脑功能障碍,在致残率、患病率上都极高,在病因上除遗传因素外,也与其他如糖尿病、高血压、不良生活习惯以及环境等有关。若未及时治疗,严重情况下将危及患者生命。通过实践研究发现,采用氯吡格雷的同时,配合前列地尔,可取得良好的治疗效果。本研究将就此进行分析。
1 资料及方法
1.1 一般资料
选取医院2014年2~6月收治的急性脑梗死患者134例,男76例,女58例,年龄45~74岁,平均(62.4±2.3)岁,平均发病时间(10.5±2.6)h,经诊断患者凝血常规时间正常,血小板>100×109/L,排除严重心肾肝功能疾病、脑肿瘤以及脑出血疾病。……
